PBMs Support and Encourage Biosimilar Competition Increased biosimilar competition drives down prescription drug costs Having multiple biosimilar and reference biologic competitor products with equivalent patient benefits on the market allows pharmacy benefit companies, PBMs, to push manufacturers to compete on
This week, community pharmacists will conduct a “Fly-In” in Washington D.C. Undoubtedly, part of the message to Congress will be critical of pharmacy benefit companies, but more than likely what won’t be heard is how PBMs are supporting rural pharmacies
Sign Up Name(Required) First Name Last Name Email(Required) Phone(Required) Consent Sign up for SMS UpdatesBy providing your phone number, you are consenting to receive calls and SMS/MMS messages, including autodialed and automated calls and texts, to that number from PCMA.
The Independent Pharmacy Marketplace Is Stable Over the last ten years, the number of independent retail pharmacies nationwide increased by 1,719 stores, or 8%. Over the last five years, the marketplace for independent pharmacies has experienced small fluctuations from year-to-year,
The Independent Pharmacy Marketplace Is Stable Over the last ten years, the number of independent retail pharmacies nationwide increased by 1,638 stores or 7.5%. New 2023 data from the National Council for Prescription Drug Programs (NCPDP) finds a continuing pattern
Unlocking an Affordable Future: Key #2 Support and Equip Clinicians SUPPORT AND EQUIP CLINICIANS WITH TOOLS AND DATA TO SERVE PATIENTS OPTIMALLY Physicians, pharmacists, and other health care providers are valued employees within pharmacy benefit companies and esteemed healthcare partners outside
(Washington, D.C.) — A new academic analysis, “Independent Pharmacies in the U.S. are More on the Rise than on the Decline,” sets the record straight on the health of independent pharmacies in the U.S. by showing the overall number of
©2024 PCMA. All Rights Reserved.
